gei_profesionales

Búsqueda de estudios

GEICAM/2017-04_KATIA

PENDIENTE DE ABRIR A multicenter, randomized, phase III study to compare the combination Trastuzumab and Capecitabine, with or without Pertuzumab in patients with HER2+ metastatic…

GEICAM/2017-04_KATIA

PENDIENTE DE ABRIR A multicenter, randomized, phase III study to compare the combination Trastuzumab and Capecitabine, with or without Pertuzumab in patients with HER2+ metastatic…

GEICAM/2017-04_KATIA

PENDIENTE DE ABRIR A multicenter, randomized, phase III study to compare the combination Trastuzumab and Capecitabine, with or without Pertuzumab in patients with HER2+ metastatic…

Páginas: